QATCH TECHNOLOGIES LLC
Chapel Hill, NC · Medtech · Private
nanovisQ™ high-throughput automated viscometer for measuring viscosity of protein biopharmaceutical formulations at wide shear rates using low sample volumes
qatchtech.com →- Grants
- $6.8M
- 11 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Microfluidic quartz resonator based blood plasma coagulation monitors | $225,000 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: High-throughput injectability screening of high concentration protein formulations by multiplexed microfluidic quartz resonators | $255,748 | |
| Federal grant | Department of Health and Human Services · Phase I · Injectability analysis of high concentration protein formulations by extending shear-rate range in microfluidic quartz viscometers | $250,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Injectability analysis of high concentration protein formulations by extending shear-rate range in microfluidic quartz viscometers | $250,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Developing prototype injectability and developability testing system based on microfluidic quartz resonators | $1,500,001 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Developing prototype injectability and developability testing system based on microfluidic quartz resonators | $598,658 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing prototype injectability and developability testing system based on microfluidic quartz resonators | $901,343 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $951,162 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $951,162 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $45,000 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $886,907 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1895 | REQUISITE BIOMEDICAL, LLC | — | — |
| 1896 | POWERSCOPE, INC | — | — |
| 1897 | NANOPATHDX, INC. | — | — |
| 1898 | QATCH TECHNOLOGIES LLC | — | — |
| 1899 | VISO Therapeutics Inc. | — | — |
| 1900 | ORB XYZ, INC. | — | — |
| 1901 | NERVIVE, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.